National genomic epidemiology investigation revealed the spread of carbapenem-resistant Escherichia coli in healthy populations and the impact on public health

Yan Li,Yanyan Zhang,Xinran Sun,Yuchen Wu,Zelin Yan,Xiaoyang Ju,Yonglu Huang,Hongwei Zhou,Zhiqiang Wang,Shaolin Wang,Rong Zhang,Ruichao Li
DOI: https://doi.org/10.1186/s13073-024-01310-x
IF: 15.266
2024-04-19
Genome Medicine
Abstract:Carbapenem-resistant Escherichia coli (CREC) has been considered as WHO priority pathogens, causing a great public health concern globally. While CREC from patients has been thoroughly investigated, the prevalence and underlying risks of CREC in healthy populations have been overlooked. Systematic research on the prevalence of CREC in healthy individuals was conducted here. We aimed to characterize CREC collected from healthy populations in China between 2020 and 2022 and to compare the genomes of CREC isolates isolated from healthy individuals and clinical patients.
genetics & heredity
What problem does this paper attempt to address?